Apheresis Market worth 2.06 Billion USD by 2021

Apheresis

The Global Apheresis Market is projected to reach USD 2.06 Billion by 2021, at a CAGR of 7.7% from 2016 to 2021.

The rising incidence of chronic lifestyle diseases such as diabetes, kidney disorders, & respiratory diseases, increasing demand for blood components, and favorable reimbursement scenario are the key factors driving the growth of the market. However, scarcity of qualified donors and the high cost of apheresis machines & procedures are restraining the growth of this market.

In this report, the market is majorly segmented by product, procedure, technology, application, and region. Based on product, the market is segmented into devices and disposables. The disposables segment accounted for the largest share and will be the fastest growing market during the forecast period. This is attributed to the increasing demand for disposables and rising preference for apheresis blood collection.

                                               Download the PDF Brochure@ http://bit.ly/2Qnp41Z

On the basis of procedure, the market is segmented into automated/donor apheresis and therapeutic apheresis. Therapeutic apheresis is further segmented into therapeutic plasma exchange (TPE), therapeutic cytapheresis, photopheresis, and extracorporeal immunoadsorption (ECI). In 2015, therapeutic plasma exchange segment accounted for the largest share of the market.

The large share of this segment is attributed to the increasing prevalence and incidence of various blood disorders such as sickle-cell anemia and leukemia. The photopheresis segment is expected to register the highest CAGR during the forecast period due to the increasing demand for photopheresis in organ transplant rejection treatment.

In 2015, North America accounted for the largest share of the market, followed by Europe. The presence of established distribution channels, growing applications of apheresis products in plasma collection and fractionation, and rising number of hemophilic patients are driving the growth of the North American apheresis market. The Asia-Pacific region is expected to witness the highest growth in this market majorly due to improving healthcare infrastructure and growing economies in China and India. In addition, manufacturers are increasingly focusing on strengthening their presence in emerging APAC countries.

The global apheresis market is highly competitive in nature, with the top five companies accounting for the major market share in 2015. Some of the key players in this market are Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), Terumo BCT, Inc. (U.S.), Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan). These leading players primarily focused on product launches, acquisitions, agreements, collaborations, partnerships, and expansions to help growth in the market.

                               Get the Sample Pages for More Details@ http://bit.ly/2GWJQpO

Target Audience

  • Apheresis product manufacturers
  • Blood transfusion product manufacturers
  • Blood banks & blood collection centers
  • Hospitals & attached blood banks
  • Therapeutic apheresis service providers
  • Biopharmaceutical companies (plasma fractionation players)
  • Market research and consulting firms
  • Health insurance payers

Scope of the Report

This research report categorizes the global apheresis market into the following segments:

Global Apheresis Market, by Product

  • Apheresis Devices
    • Plasma Separators
    • Plasma Component Separators
    • Immunoadsorption Columns
    • Plasma Perfusion Columns
    • Hemoperfusion Columns
  • Apheresis Disposables

Global Apheresis Market, by Procedure

  • Automated/Apheresis Blood Collection (Donor Apheresis)
  • Therapeutic Apheresis
    • Therapeutic Apheresis Market, by Disease
      • Neurological Disorders
      • Blood Disorders
      • Cardiovascular Disorders
      • Renal Disorders
      • Autoimmune Disorders
      • Metabolic Disorders
      • Other Disorders
    • Therapeutic Apheresis Market, By Procedure
      • Therapeutic Plasma Exchange (TPE)
      • Therapeutic Cytapheresis
        • Therapeutic Erythrocytapheresis
        • Therapeutic Plateletpheresis
        • Leukapheresis
      • Photopheresis
      • Extracorporeal Immunoadsorption (ECI)

Global Apheresis Market, by Technology

  • Centrifugation
    • Intermittent Flow
    • Continuous Flow
  • Membrane Separation

Global Apheresis Market, by Application

  • Plasmapheresis
  • Plateletpheresis
  • Erythrocytapheresis
  • Leukapheresis
  • Other Applications

Global Apheresis Market, by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia-Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia-Pacific (RoAPAC)
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America (RoLA)
  • The Middle East and Africa

Read More@
https://www.marketsandmarkets.com/Market-Reports/apheresis-market-950.html

Share this post:

Related Posts

Comments are closed.